checkAd
    Startseite > Aktien > NanoVibronix > Nachrichten
    NanoVibronix Aktie
    0,6825
     
    EUR
    +5,00 %
    +0,0325 EUR
    Letzter Kurs 09:45:36 Lang & Schwarz
    0,6550
     
    EUR
    9.288 STK
    Geldkurs 09:45:36
    0,7100
     
    EUR
    9.288 STK
    Briefkurs 09:45:36
    ISIN: US63008J6038 · WKN: A3D578 · USA

    Neueste Nachrichten

    NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award
    01.05.24 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Issues Letter to Stockholders
    09.04.24 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
    28.03.24 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Featured in Your Bladder Health Magazine
    06.12.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
    04.12.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
    28.11.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Regains Nasdaq Compliance
    21.11.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Issues Letter to Shareholders
    14.11.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
    07.11.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
    27.09.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
    06.09.23 · Business Wire (engl.) · NanoVibronix
    NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
    30.08.23 · Business Wire (engl.) · NanoVibronix